Park, H.A.,
Neumeyer, S.,
Michailidou, K.,
Bolla, M.K.,
Wang, Q.,
Dennis, J.,
Ahearn, T.U.,
Andrulis, I.L.,
Anton-Culver, H.,
Antonenkova, N.N.,
Arndt, V.,
Aronson, K.J,
Bermisheva, M.,
other authors (2021) single-nucleotide polymorphisms (SNPs) reported in genome-wide
association studies of lifetime smoking
Korytina, G.F.,
Akhmadishina, L.Z.,
Kochetova, O.V.,
Aznabaeva, Y.G.,
Zagidullin, Sh.Z.,
Victorova, T.V. (2016) as a case–control
study aimed at investigating the
association of COPD with polymorphisms
FEDOROVA, Y.Y.,
KARUNAS, A.S.,
GIMALOVA, G.F.,
KHUSNUTDINOVA, E.K.,
SAVELIEVA, O.N,
MURZINA, R.R.,
GATIYATULLIN, R.F.,
ETKINA, E.I. (2019) –60% of differences in sensitivity to therapy in patients with BA is due to genetic variability. We
studied thus be detected via combining effect size estimates from genetic
association studiesTimasheva, Yu.,
Zudina, L.,
Balkhiyarova, Zh.,
Kaakinen, M.,
Munroe, P.,
Prokopenko, I. (2019) pathophysiological mechanisms. Large-scale genome-wide
association studies (GWAS) have revealed hundreds of genetic
DAVYDOVA, YU. D.,
KAZANTSEVA, A. V.,
ENIKEEVA, R. F.,
MUSTAFIN, R.N.,
ENIKEEVA, R. F.,
LOBASKOVA, M. M.,
MALYKH, S. B.,
GILYAZOVA, I.R.,
KHUSNUTDINOVA, E.K. (2020) aggression, the present
study aimed to assess the main effects of the OXTR (rs53576, rs237911, rs7632287, rs
KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, N.SH.,
ZAGIDULLIN, SH.Z.,
KZHYSHKOWSKA, J.G (2019) parenchyma. This work was designed as a case-control
study aimed at investigating the
association of the NRF2
parenchyma. This
study was aimed at investigating the
association of COPD with IREB2, CHRNA5, CHRNA3, FAM13A